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Abstract
In the last fifteen years, rapid progress has been made in delineating the cellular response to DNA damage. The
DNA damage response network is composed of a large number of proteins with different functions that detect
and signal the presence of DNA damage in order to coordinate DNA repair with a variety of cellular processes,
notably cell cycle progression. This signal, which radiates from the chromatin template, is driven primarily by phos-
phorylation events, mainly on serine and threonine residues. While we have accumulated detailed information
about kinases and their substrates our understanding of the role of phosphatases in the DNA damage response is
still preliminary. Identifying the phosphatases and their regulation will be instrumental to obtain a complete picture
of the dynamics of the DNA damage response. Here we give an overview of the DNA damage response in mam-
malian cells and then review the data on the role of different phosphatases and discuss their biological relevance.
Introduction
Maintenance of genomic integrity is an essential part of
cellular physiology. Genotoxic insults that induce DNA
breaks must be repaired in order to prevent the propa-
gation of mutations that can contribute to malignant
transformation. DNA damage occurs following a variety
of stimuli including ionizing radiation (IR), ultraviolet
radiation (UV), replication stress, chemicals from the
environment, and reactive oxygen species that are pro-
duced as a byproduct of cellular metabolism.
The processes by which cells repair damage to DNA
and coordinate repair with cell cycle progression are
collectively known as the DNA damage response (DDR).
In cases in which the damage cannot be repaired, pro-
longed cell cycle arrest can lead to senescence or the
induction of apoptotic signals [1-3]. Signaling through
the DDR occurs through a series of distinct but inter-
connected pathways that are better visualized as a net-
work [4]. This network includes proteins that have been
classified as sensors, signal transducing proteins, effector
kinases, mediators, and effector proteins (Fig. 1) [1].
Although this classification is arbitrary and the distinc-
tion is sometimes blurred, it facilitates our global under-
standing of the information flow in the network.
Analogous to growth factor receptor signaling, DNA
damage signaling is also driven primarily by changes in
protein localization and post-translational modifications.
Among post-translational modifications, serine and
threonine phosphorylations occupy central stage (Addi-
tional file 1, Table 1). Although there has been signifi-
cant progress in our understanding of the role of these
phosphorylations and the regulation of DDR kinases [5],
our knowledge of the role of dephosphorylations and
phosphatase regulation in this context is still rudimen-
tary. Here we provide an overview of DDR signaling and
then discuss recent work that sheds light on how phos-
phatases are critical to the fine regulation of the DDR.
Sensing the damage and activating the
initial response
DNA damage is recognized by sensor proteins that initi-
ate the activation of the DDR on chromatin. These sen-
sors include the Mre11-Rad50-Nbs1 (MRN) and the
Rad9-Rad1-Hus1 (9-1-1) complexes that localize to dou-
ble stranded breaks (DSBs) or regions of replication
stress and single stranded breaks, respectively [6,7] (Fig.
1). Mre11 binds to Nbs1, DNA, and Rad50 and pos-
sesses DNA exonuclease, endonuclease, and unwinding
activities [8]. While Rad50 may function to keep the
broken ends of the DNA together, Nbs1 functions to
recruit signal transducing kinases to the break site and
mediates the DDR signal [9]. The structure of the 9-1-1
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(PCNA) sliding clamp that is loaded onto DNA at
points of replication [6]. The Rad17-replication factor C
(RFC) complex acts as the 9-1-1 clamp loader in a pro-
cess analogous to RFC acting as the clamp loader for
PCNA [10]. In a process that is not fully understood,
localization of the MRN and 9-1-1 complexes to the
sites of DNA damage in chromatin signals to activate
the signal transducing kinases Ataxia-telangiectasia
mutated (ATM), the ATM and Rad3-related (ATR)
kinase, and the DNA-dependent protein kinase (DNA-
PK), which are members of the phosphoinositide
3-kinase related kinase family.
Primarily in response to DSB, ATM dissociates from
inactive dimers into active monomers [11]. Elegant bio-
chemical and cell biological experiments led to the idea
that ATM autophosphorylation at S1981 caused disso-
ciation and was intimately linked to initiation of kinase
activity [11]. However, recent mouse studies have shown
that phosphorylation at S1981 is not required for ATM
activation in vivo [12,13]. Rather, it seems to be required
for the retention of ATM at the DSB sites through asso-
ciation with the mediator MDC1 [14]. Nbs1 seemingly
acts both upstream and downstream of ATM, reinfor-
cing the notion of a network rather than a linear path-
way. ATM is known to phosphorylate Nbs1 on S343
and at the same time, Nbs1 and the MRN complex are
required for full activation of ATM [9,15,16]. Along
similar lines, the localization of ATR to the break site
and its subsequent activation is dependent upon the
9-1-1 complex, binding between ATR and ATR-interact-
ing protein (ATRIP), and replication protein A (RPA).
RPA coats single-strand DNA and consists of 3 subu-
nits: RPA70, RPA32, and RPA14 [17]. RPA32 is
phosphorylated at T21 and S33 by ATM, ATR, and
DNA-PK [18].
DNA-PK is part of the phosphoinositide 3-kinase
related kinase family with ATM and ATR and is acti-
vated upon association with DNA [19]. DNA-PK is
comprised of a catalytic subunit, DNA-PKcs, and the
targeting subunit, the Ku70-Ku80 heterodimer [19]. The
primary role of DNA-PK is to initiate non-homologous
Figure 1 A simplified view of the cellular response to DNA damage. Single and double stranded DNA breaks signal through the sensors
(MRN and 9-1-1) shown in purple, mediators (H2AX, BRCA1, MDC1, 53BP1) shown in blue, signal transducing kinases (ATM, ATR) shown in
yellow, effector kinases (CHK2, CHK1) shown in pink, and effector proteins (E2F1, p53, Cdc25) shown in green, leading to gene transcription,
apoptosis, and cell cycle arrest. Proteins that are phosphorylated by ATM, ATR, and/or DNA-PK are marked by a yellow phosphate group and
proteins that are phosphorylated by CHK2 and/or CHK1 are marked by a pink phosphate group.
Freeman and Monteiro Cell Communication and Signaling 2010, 8:27
http://www.biosignaling.com/content/8/1/27
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hosphorylation clusters in DNA-PKcs (referred to as
ABCDE and PQR) regulate the ability of DNA-PK to
function in DNA end processing during repair although
the exact role of these phosphorylation events is not yet
known [20]. Finally, recent proteomics approaches in
yeast and mammalian cells have greatly expanded the
list of potential substrates of kinases involved in the
DNA damage response [21,22].
Effector kinases and mediators:
transducing the signal
The signal transducing kinases ATM and ATR signal
through the effector kinases CHK1 and CHK2 (check-
point kinase 1 and checkpoint kinase 2), which sustain
and amplify the DDR signal [23]. Importantly, CHK1
and CHK2 are highly mobile messengers that are not
restricted to chromatin compartments and are thus able
to relay the message from complexes formed at or near
breaks to other cellular substrates [24]. CHK2 is acti-
vated primarily in response to DSB through the phos-
phorylation of T68 by ATM [25-27] and subsequent
oligomerization and autophosphorylation at T383 and
T387 [28,29]. CHK1 is active even in unperturbed cells,
but is further activated through the phosphorylation of
S317 and S345 by ATR, primarily in response to single
stranded breaks and replication stress [23].
The relative contributions of the effector kinases in
development have been highlighted using mouse mod-
els. While Chk2-deficient mice are viable and do not
have an increased risk for cancer, Chk1-deficient mice
are embryonic lethal [30-33]. Although it is difficult to
pinpoint which activities of CHK1 might be essential it
is conceivable that CHK1 acts as the “workhorse” in
responding to replication stress, which likely occurs in
every cell cycle, while CHK2 functions in an inducible
fashion after DNA damage caused by other stimuli.
CHK1 also has important functions during normal cell
division, as it was found to associate with centrosomes
in interphase and regulate their separation [34].
Several mediator proteins such as H2AX, BRCA1,
MDC1, Claspin, and 53BP1 work to coordinate the loca-
lization of various factors in the DDR, promote their
activation, and regulate substrate accessibility [35]. The
histone variant H2AX is phosphorylated by ATM, ATR,
and DNA-PK on S139 upon DNA damage and this
phosphorylated form is also known as g-H2AX [36].
g-H2AX forms nuclear foci visible through immuno-
fluorescence that are both proximal and distal to the
DSB site and is considered a marker for the presence of
DSB [37]. g-H2AX is required for the efficient retention
of Nbs1 and the other mediator proteins BRCA1,
MDC1, and 53BP1 at damage-induced foci [38-44].
BRCA1 is a target of multiple phosphorylations
although for many of them the biological significance is
largely unclear (reviewed in [45])(Table 1). BRCA1
S1387 and S1423 are targets of phosphorylation by
ATM and these phosphorylations are required for the
intra-S and G2/M checkpoints, respectively [46-48]
(Table 1). The S1387 site can also be phosphorylated by
ATR and DNA-PK [49] perhaps ensuring a tight control
of the intra-S checkpoint. The effector kinase CHK2 can
phosphorylate BRCA1 on S988 in response to IR
[50-52] but the functional consequences are still not
clear. In response to UV, BRCA1 is also phosphorylated
by ATR on S1457 [53]. Phosphorylated BRCA1 forms
distinct nuclear foci that co-localize with g-H2AX,
M D C 1 ,a n dt h eM R Nc o m p l e x .T h er o l eo fB R C A 1i n
the complex seems to be to coordinate repair through
both non-homologous end joining and homology-direc-
ted recombination [54,55].
MDC1 is phosphorylated in an ATM- and CHK2-
dependent manner, and its BRCT domain directly
recognizes the phosphoserine 139 in the carboxy end of
g-H2AX (Table 1) [42,56]. Recruitment of MDC1 to
g-H2AX foci is required for the formation of MRN,
BRCA1, and 53BP1 foci [39,42,57]. Thus, MDC1 func-
tions as a molecular scaffold to mediate parts of the
DDR downstream of foci formation [58]. Claspin is a
major regulator of the activity of CHK1 and binds DNA
with high affinity. After DNA damage or replication
stress Claspin is phosphorylated by CHK1, an event that
is required for a Claspin-CHK1 interaction and subse-
quent full activation of CHK1 by ATR, in another exam-
ple of the network nature of the DDR [59-63].
Effector proteins: control of cell cycle progression
The effector proteins Cdc25, p53, and E2F1 function to
activate cell cycle checkpoints and regulate the tran-
scription of genes whose products are important in the
end result of the DDR, whether it be DNA repair, apop-
tosis, or senescence.
The Cdc25 phosphatases regulate cell cycle progres-
sion by removing inhibitory Y15 phosphorylations from
the cyclin-dependent kinases Cdk1 and Cdk2 [64]. The
negative regulation of Cdc25 leads to the activation of
G1/S, intra-S, and G2/M checkpoints. CHK1 phosphory-
lates Cdc25A on S76, leading to Cdc25A ubiquitination
and degradation [65]. CHK1 and CHK2 also phosphory-
late Cdc25A on S123, S178, S278, and S292 which leads
to its IR-induced degradation [66]. CHK1 and CHK2
phosphorylate Cdc25C on S216 which allows 14-3-3
binding and subsequent sequestration of Cdc25C in the
cytoplasm, away from substrates. Cdc25B is phosphory-
lated on S309, leading to inactivation through the same
14-3-3-mediated mechanism [64,67,68].
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activate the transcription of genes whose products parti-
cipate in cell cycle arrest, DNA repair, senescence, or
apoptosis, depending upon the stimulus [69]. Mdm2
negatively regulates p53 through ubiquitin-mediated
proteosomal degradation [70-72]. MdmX also negatively
regulates p53 by binding to Mdm2 and enhancing
Mdm2 binding to and ubiquitination of p53 [73-75].
ATM, ATR, and DNA-PK phosphorylate p53 on S15,
while CHK1 and CHK2 phosphorylate p53 on S20
which stabilize p53 by preventing binding to Mdm2
[76-78]. ATM and ATR also directly inhibit Mdm2 by
phosphorylating it on S395 and S407, respectively
[79,80]. ATM phosphorylates MdmX on S403 which
leads to its ubiquitination and degradation [81] whereas
CHK2 phosphorylates MdmX on S367 and S342 which
promotes 14-3-3 binding and degradation of MdmX
[82,83]. Therefore, multiple DDR proteins coordinate to
stabilize and activate p53 through phosphorylation of
p53 and its negative regulators Mdm2 and MdmX.
The transcription factor E2F1 is also activated by
phosphorylation in response to DNA damage. ATM and
CHK2 phosphorylate E2F1 on S31 and S364, respec-
tively, which leads to E2F stabilization [84,85]. Accumu-
lation of E2F1 leads to increased transcription activation
and apoptosis, although the specific genes that are
responsible for these cellular effects have not yet been
determined [84,85].
Fine-tuning the DDR: role of serine/threonine
phosphatases
A simplistic reading of the scenarios described above
suggests a unidirectional wave of phosphorylation events
radiating from the site of damage that is progressively
amplified to relay the signal to a large number of sub-
strates in the cell (Fig. 1). Unfortunately, the biological
relevance of many of these phosphorylated events is still
unknown. These phosphorylated linear motifs are
mainly recognized by 14-3-3 proteins, and by FHA and
BRCT modular domains (Additional file 1, Table 1)[58].
We have little information about the dynamics of this
system and although at first approximation it might
seem a bistable system (stable “on” or “off” states),
recent data have suggested the upstream kinases such as
ATM and CHK2 signal in pulses [86,87]. Batchelor et al.
experiments suggest that these pulses arise from peri-
odic examinations of the status of the damage by ATM
[86]. In any event, it is clear that fine-tuning of the
response depends on the activity of phosphatases in
order to prevent illegitimate activation of the DDR in
the absence of damage as well as to allow rapid cessa-
tion of the signal once DNA is repaired.
Since much of the signaling of the DDR is relayed by
serine and threonine phosphorylation, it is intuitive that
protein serine/threonine phosphatases would negatively
regulate these phosphorylation events. Indeed, there are
many proteins in the DDR that are negatively regulated
in this manner, although there are also specific cases in
which certain phosphatases enhance the activity of
proteins in the pathway (Additional file 1, Table 1 and
Fig. 2).
There are two major families of protein serine/threo-
nine phosphatases. The phosphoprotein phosphatases
include PP1, PP2A, PP2B (also known as PP3 or calci-
neurin), PP4, PP5, PP6, and PP7. The metal-dependent
protein phosphatases, which require Mg
2+ or Mn
2+ for
enzymatic activity, include PP2C (reviewed in [88,89]).
Phosphatase action on chromatin
Multiple phosphatases have been implicated in nega-
tively regulating g-H2AX. In yeast, deletion of any gene
of the PP4-like complex HTP-C (Pph3, Psy2, and
Ybl046w) increased the amount of cellular g-H2AX.
Although Pph3 deficient cells had similar rates of DSB
repair and loss of g-H2AX foci as wild-type cells, Rad9
and Rad53 (orthologs of human 53BP1 and CHK2,
respectively) remained active longer and this correlated
with maintenance of the G2/M checkpoint [90].
Pharmacologic inhibition of PP2A or knockdown with
siRNA increased the amount of total g-H2AX, the num-
ber of g-H2AX foci-positive cells, the intensity of the
foci, and the amount of time the foci were maintained
following treatment with the topoisomerase I inhibitor
camptothecin [91]. Indeed, PP2A C co-localized with
and bound to g-H2AX after camptothecin treatment
and the binding increased with increasing DNA damage
[91]. Along similar lines, the inhibition of PP1 partially
inhibited the elimination of g-H2AX in human cells
after IR [92]. Although PP1 has been shown to depho-
sphorylate g-H2AX in nucleosomes in vitro, PP2A is at
least 25 times more active toward g-H2AX in mono-
meric form or when incorporated into nucleosomes
[91,92].
In cells with both PP4C and PP2A C knocked-down,
g-H2AX levels were higher and sustained longer after
camptothecin treatment as compared to control cells
[93]. PP2A C and PP4C had comparable abilities to
dephosphorylate g-H2AX from mononuclosomes in
vitro [93] and knockdown of PP4C and PP2A C also
caused an increase in the total levels of g-H2AX in
untreated and IR-treated cells [94]. Further examination
of the specific roles of PP2A and PP4 in the regulation
of g-H2AX revealed distinct roles for each phosphatase.
PP4C-silenced cells, but not PP2A-silenced cells, showed
an increase in g- H 2 A Xe v e ni nt h ea b s e n c eo fD N A
damage [93]. PP2A C-silenced cells were slightly wea-
kened in the ability to repair DSBs induced by X-rays
while PP4C-silenced cells were not impaired in DNA
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g-H2AX foci after IR but PP2A knockdown did not
affect foci. PP4C primarily dephosphorylated g-H2AX
associated with chromatin rather than in the nucleo-
plasm, whereas PP2A did not. Finally, PP4C depleted
cells delayed entry into mitosis, but did not have any
problems with the initiation of the G2/M checkpoint
[94].
PP6 can also negatively regulate g-H2AX through
binding to DNA-PK. The DNA-PK/PP6 catalytic subunit
complex was disrupted by DNA-PK autophosphoryla-
tion and phosphorylation of PP6 [95]. Depletion of PP6
via siRNA prior to IR caused a sustained phosphoryla-
tion of H2AX with persistence of g-H2AX and 53BP1
foci, increased radiation sensitivity, and a delayed exit
from G2 [95].
Finally, Wip1 (Wild-type p53-induced phosphatase 1,
also known as PPM1 D or PP2Cδ) was found to bind to
H2AX, associate with the chromatin throughout the cell
cycle, and co-localize with g-H2AX in IR-induced foci
[96]. Overexpression of Wip1 resulted in a significantly
impaired induction of g-H2AX after IR and UV and
decreased g-H2AX foci staining in an ATM-independent
manner [96,97]. The spleen tissue of Wip1
-/- mice had
higher basal levels of g-H2AX than Wip1
+/+ mice in the
absence of DNA damage as well as higher levels of
g-H2AX after IR [97]. Interestingly, overexpression of
Wip1 inhibited the formation of MDC1 and 53BP1 foci
[96,97]. Silencing of Wip1 also resulted in more efficient
repair of the break since Wip1 inhibited both homol-
ogy-directed recombination and non-homologous end
joining [97].
Thus, several phosphatases (PP2A, PP4, PP1, PP6, and
Wip1) participate directly or indirectly in the depho-
sphorylation of g-H2AX. It is still not clear what the
exact contribution of each phosphatase is but the emer-
ging data suggest some level of redundancy as well as
some context-dependent specificity. In addition,
although it seems clear that serine/threonine phospha-
tases predominate in DDR signaling, tyrosine
Figure 2 Protein serine/threonine phosphatases in the DNA damage response pathway. The positive (arrows) and negative regulation of
DDR proteins via protein serine/threonine phosphatases is shown.
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shown that Eyes Absent tyrosine phosphatases are
involved in the dephosphorylation of the H2AX Y142
residue which is involved in the formation of g-H2AX
foci [98].
PP2A is also involved in the regulation of Replication
Protein A (RPA) which coats single stranded DNA [99].
The RPA-coated ssDNA actsa st h es u b s t r a t ef o r
RAD51 recombinase and mediates the DNA strand
invasion during homology-directed recombination
[99,100]. After treatment and removal of hydroxyurea,
when RPA is phosphorylated, RPA32 is progressively
dephosphorylated at T21 and S33. Inhibition of PP2A
with okadaic acid or knockdown via siRNA results in
persistence of RPA phosphorylation and foci [101]. An
RPA mutant that could not be dephosphorylated
resulted in reduced cell viability following UV or hydro-
xyl urea treatment and reduced DNA repair following
replication stress [101].
Regulating the proximal kinases ATM, ATR,
and DNA-PK
The first evidence that PP2A might play a role in the
ATM-dependent DDR came from the finding that the
PP2A B subunit dissociates from the PP2A heterotrimer
in the nucleus in an ATM-dependent manner after IR
[102]. It was later found that inhibition of PP2A with
okadaic acid or expression of a dominant-negative PP2A
C increased ATM autophosphorylation at S1981 under
normal conditions, but did not affect ATM activity.
ATM binds to the A and C subunits, but this binding is
disrupted after IR, partially in an ATM-dependent man-
ner [103]. PP2A was able to dephosphorylate ATM
S1981, but not as efficiently as Wip1 [104], described
below.
Two different Wip1 mouse models have revealed a
role for Wip1 in negatively regulating Atm [104,105].
E1A+Ras expressing Wip1-null mouse embryo fibro-
blasts (MEFs) have an increase in Atm phosphorylation
at S1987 (corresponding to human ATM S1981) and an
increase in Atm activity under normal conditions as
well as after IR. Phosphory l a t i o no fp 5 3S 1 8( h u m a n
S15), the Atm phosphorylation site, was increased
slightly as well [104]. Indeed, Wip1 was found to depho-
sphorylate Atm at S1981, S367 and S1893 in vitro
[104,105]. Splenocytes from Wip1
+/- and Wip1
-/- mice in
an Eμ-myc background displayed an increase in Atm
phosphorylation and p53 S18 phosphorylation [105].
Interestingly, Wip1
+/- and Wip1
-/- mice were more resis-
tant to tumor formation and this was dependent on
Atm and p53 [105].
In human cells, the overexpression of Wip1 decreased
ATM autophosphorylation and ATM-dependent CHK2
phosphorylation after IR. The induction of Wip1 protein
levels in control cells correlated with the decrease in
phosphorylated ATM after IR. ATM phosphorylation
also remained longer after IR in cells with lower levels
of Wip1 [104]. Another study, however, used a tetracy-
cline-inducible Wip1 and showed that the expression of
Wip1 after IR did not have an effect on ATM S1981
phosphorylation [106]. This difference may be due to
the different cell lines and conditions used.
In contrast to PP2A and Wip1 which suppress ATM
activation, PP5 plays an important role in the activation
of the DDR through ATM. Cells with decreased PP5
protein or activity exhibited a decrease in ATM autop-
hosphorylation at S1981, a decrease in ATM kinase
activity, and a phenotype of radio-resistant DNA synth-
esis after DNA damage, which is consistent with the
phenotype of cells lacking ATM [107]. PP5-deficient
MEFs displayed a defect in the G2/M checkpoint after
IR, a decrease in Atm activity, and less phosphorylation
of the Atm targets Chk2 and Nbs1 after DNA damage
[108]. Interestingly, PP5 was found to bind to ATM,
and this binding was increased after treatment with IR
or neocarzinostatin (which causes DSB) [107].
In addition to its role in activating ATM, PP5 was
also shown to be important for the activation of ATR.
PP5 can bind to ATR after treatment with neocarzinos-
tatin, UV, and hydroxyurea (which mimics replication
stress). PP5 was necessary for the phosphorylation of
CHK1 at S345, and the knockdown of PP5 inhibited the
replication checkpoint after UV, inhibited the S-phase
checkpoint after hydroxyurea, and decreased RPA phos-
phorylation and foci formation [109].
PP1, PP2A, and PP6 have all been shown to positively
influence DNA-PK activity. When PP1 was added to
DNA-PK complexes that were induced to autopho-
sphorylate, the reduction in activity and disruption of
the DNA-PK-DNA binding due to the autophosphoryla-
tion were reversed [110]. PP2A dephosphorylated DNA-
PKcs as well as Ku70 and Ku80 leading to increased
DNA-PK activity [111]. This opposes the autophosphor-
ylation of DNA-PK that results in decreased activity of
DNA-PK [112]. Camptothecin-induced DSB increased
the association between PP2A and Ku proteins. PP2A
dephosphorylation of DNA-PKcs and Ku increased the
association between the DNA-PK proteins and this pro-
moted DNA repair [113].
PP6 and DNA-PK form a complex in cells and bind-
ing increased after IR [114]. IR caused a translocation of
DNA-PK and PP6 from the cytoplasm to the nucleus
and it appears that localization of the phosphatase is
dependent on the kinase and vice versa. Knockdown of
PP6 almost completely abolished the increase in DNA-
PK activity after IR, caused a defect in DSB repair, and
resulted in clonogenic survival after IR similar to DNA-
PK knockdown cells [114].
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CHK1 has been shown to be negatively regulated by
multiple protein serine/threonine phosphatases. In Schi-
zosaccharomyces pombe, the PP1 homologue Dis2 nega-
tively regulates CHK1 [115]. Cells lacking Dis2 had a
p r o l o n g e dG 2a r r e s tf o l l o w i n gt r e a t m e n tw i t ht h eD S B
inducer methylmethane sulfonate or the UV mimetic 4-
nitroquinoline-N-oxide but DNA repair was not affected
[115]. The overexpression of Dis2 caused a decrease in
CHK1 activation following UV [115]. Indeed, CHK1
S345 could be dephosphorylated in vitro by Dis2 or
human PP1 [106,115]. However, caution should be exer-
cised when extrapolating data from yeast to mammalian
systems as there are notable differences in the DDR,
particularly at the level of CHK1 and CHK2 [116,117].
In human cells, the inhibition of PP2A induced CHK1
phosphorylation in the absence of DNA damage and
also prevented CHK1 dephosphorylation after hydro-
xyurea removal [118]. The knockdown of PP2A
increased CHK1 phosphorylation on S317 and S345 and
in vitro, PP2A was able to directly dephosphorylate
CHK1 [118]. In X. laevis egg extracts, the addition of
PP2A C reversed CHK1 phosphorylation at S344
(human S345) after activation by DSB [119]. The inhibi-
tion of PP2A also enhanced CHK1 phosphorylation fol-
lowing activation by DSB [119].
Human CHK1 is also regulated by Wip1. Wip1 could
dephosphorylate CHK1 primarily at S345 and slightly at
S317 in vitro. In vivo, the overexpression of Wip1
resulted in the elimination of CHK1 phosphorylation at
S345 and S317, a decrease of Cdc25C phosphorylation
at S216, a decrease in Cdk1 phosphorylation at Y15, and
a decrease in the S-phase and G2/M checkpoints,
whereas the knockdown of Wip1 via siRNA caused the
reverse effects [106]. Breast cancer cell lines overexpres-
sing Wip1 (MCF-7, BT474, and MDAMB231) showed
only a marginal increase in CHK1 S345 phosphorylation
after UV as compared to the control cells (HEK and
U2OS) [106]. Interestingly, Wip1
-/- MEFs in a 129/sv-
C57BL6 background showed a greater increase in phos-




sing Eμ-myc did not show any difference in Chk1 S345
phosphorylation, possibly indicating a cell type specific
or DNA damage specific regulation of CHK1 via Wip1
[105,106]. In summary, CHK1p h o s p h o r y l a t i o na tS 3 1 7
and S345 and CHK1 activity following DNA damage are
regulated by PP1, PP2A, and Wip1. These phosphatases
seem to play an important role in recovery from the
DDR checkpoints.
Much of the work examining the negative regulation
of CHK2 has been done using the Saccharomyces cerevi-
siae CHK2 homologue Rad53. The PP2C phosphatases
Ptc2 and Ptc3 as well as the type 2A phosphatase Pph3
have all been shown to negatively regulate Rad53 under
different circumstances. To study DSB in yeast, a system
that induces the HO endonuclease to create a single
DSB at a specific locus that cannot be repaired by
homologous recombination was utilized. A single break
will cause a G2/M arrest and then adaptation to the
checkpoint. Cells lacking Ptc2 and/or Ptc3 were defec-
tive in adaptation to an HO-induced G2/M arrest. Ptc2
and Ptc3 were required for recovery from the check-
point as measured by Rad53 dephosphorylation and
release from the G2/M checkpoint [120,121]. Ptc2 and
Ptc3 were found to bind to the FHA1 domain of Rad53
and CK2 phosphorylation of Ptc2 at T376 was necessary
for this interaction [120,121]. Mutation of this site pre-
vented adaptation and recovery of the G2/M checkpoint
[121]. Therefore, Ptc2- and Ptc3-mediated dephosphory-
lation of Rad53 results in recovery from the G2/M
checkpoint.
Also in S. cerevisiae, deletion of the PP2A-like phos-
phatase Pph3 caused hypersensitivity to methylmethane
sulfonate [122]. Pph3-Psy2 bound to Rad53 and depho-
sphorylated it directly. The Pph3-Psy2 complex was
necessary for the dephosphorylation of Rad53 during
recovery from the intra-S-phase checkpoint and it pro-
moted the resumption of normal DNA synthesis follow-
ing removal of methylmethane sulfonate [122].
One study attempted to differentiate the roles of Pph3,
Ptc2, and Ptc3 in negatively regulating Rad53. Cells
lacking Pph3 again showed hyperphosphorylation of
Rad53, but Rad53 was still deactivated after methyl-
methane sulfonate treatment and removal [123]. Cells
lacking Pph3, Ptc2, and Ptc3 have impaired Rad53 deac-
tivation following MMS treatment, although Rad53
deactivation from replication stress was slightly delayed.
Pph3 was not required for Rad53 dephosphorylation
and deactivation following replication stress. Ptc2 and
Ptc3 were not required for Rad53 deactivation and
dephosphorylation following genotoxic stress in S-phase
via hydroxyurea [123]. Thus, distinct phosphatases
appear to be required for the dephosphorylation and
deactivation of Rad53 following various DNA damages
in yeast and the phosphatase required for recovery from
replication stress has not yet been identified.
In humans, CHK2 was found to be regulated by PP2A
and Wip1. Inhibition of PP2A using okadaic acid
increased the phosphorylation of CHK2. Although PP2A
was also found to negatively regulate ATM, the effect
on CHK2 phosphorylation was ATM-independent [103].
Utilizing a yeast two-hybrid system, an in vitro binding
assay, and co-immunoprecipitation, CHK2 was found to
bind to PP2A A, C, and many B’ subunits. CHK2 was
able to phosphorylate B’g1a n dB ’g3i nv i t r oa n dt h i s
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B’g3 resulted in a decrease in CHK2 phosphorylation
after doxorubicin treatment, which causes DNA adducts
[124]. Following cisplatin treatment, PP2A containing a
B subunit was found to bind to CHK2. Inhibition of
PP2A with okadaic acid or knockdown via siRNA
caused an increase in CHK2 phosphorylation at T68.
PP2A was found to dephosphorylate CHK2 in vitro as
well [125].
Recent work from our laboratory has identified the
B’a subunit of PP2A as a CHK2 binding partner [126].
B’a was found to bind to the SQ/TQ repeat region of
CHK2, which is a target of ATM phosphorylation. The
induction of DNA DSB by IR as well as treatment with
doxorubicin caused a dissociation of the B’a and CHK2
proteins due to ATM-dependent phosphorylation of
CHK2 serines 33 and 35. PP2A negatively regulates
CHK2 phosphorylation at multiple sites including T68
as well as its kinase activity [126]. The subsequent
reconstitution of the PP2A/CHK2 complex in later time
points after damage may help to attenuate the signal
[87,126,127].
Wip1 and CHK2 were found to bind in the nucleus
and binding was dependent upon the CHK2 SQ/TQ
domain, kinase activity, and nuclear localization signal
and the Wip1 N-terminal domain [128,129]. Endogen-
ous Wip1 and CHK2 could bind in MCF7 cells, which
have a higher expression level of Wip1 and in A549
cells [128,129]. Using GST-Wip1 in a GST pull down
assay with lysates of HCT15 cells stably expressing HA-
CHK2, Wip1 was seen to bind to CHK2 only after IR,
suggesting that CHK2 phosphorylation is important for
the interaction [130]. In vitro, Wip1 could dephosphory-
late CHK2 at multiple sites including T68 and this sig-
nificantly reduced CHK2 kinase activity [129,130].
Overexpression of Wip1 inhibited CHK2 kinase activity
in vitro, and in vivo, decreased T68 phosphorylation,
caused a delay in CHK2 activation following IR, and
caused a delay in G2/M arrest [129,130]. Knockdown of
Wip1 resulted in sustained CHK2 T68 phosphorylation
and kinase activity following IR, as well as an increase in
apoptosis [129]. In the acute promyelocytic leukemia
cell line NB4, arsenic trioxide could induce CHK2 T68
phosphorylation through the inhibition of Wip1 [131].
Finally, in stomach adenocarcinoma tumors, high Wip1
expression correlated with low CHK2 phosphorylation
[132].
PP1 could dephosphorylate BRCA1 at the CHK2 tar-
get site S988, the ATM target site S1524, and the ATR
site S1423 [133,134]. The overexpression of PP1 partially
inhibited the hyperphosphorylation of BRCA1 after IR
[134]. Since PP1 was shown to dephosphorylate BRCA1
at sites that have been shown to be important for
BRCA1 function, it was intriguing to find that PP1 may
actually act to enhance BRCA1 function. PP1 specifically
binds to BRCA1 amino acids 898-901 (KVTF) [133,135].
Mutation of this site negatively affected homology-direc-
ted recombination and the localization of the HR factor
R a d 5 1t ot h eb r e a ks i t e ,w h i c ha r ef u n c t i o n so fB R C A 1
[133]. Interestingly, in human tissues, PP1 mRNA levels
were significantly higher in normal tissue as compared
to sporadic breast tumors [135]. This implicates PP1 in
the regulation of BRCA1 function.
Regulating the effectors
In addition to being regulated by MDM2, p53 is also
negatively regulated through direct dephosphorylation
by PP1 and PP2A. PP2A bound to p53 following IR and
dephosphorylated S37 [136], whose phosphorylation via
CHK1 and CHK2 is required for p53 transcriptional
activity [77,137]. Inhibition of PP2A with okadaic acid
or knock-down via siRNA caused an increase in p53
phosphorylation at S15 and an increase in p53 activity
[136].
Inhibition of PP1, but not PP2A, with okadaic acid
induced the p53 target Bax and, consequently, apoptosis
in rabbit lens epithelial cells [138]. Inhibition of PP1
only slightly increased p53 levels but dramatically
increased p53 phosphorylation at S15 and S37 which
enhanced regulation of p53 targets Bcl2 and Bax. PP1
dephosphorylated p53 at S15 and S37 in vitro and in
vivo and this decreased its transcriptional activity and
attenuated apoptosis [139].
Importantly, Wip1 was induced in response to IR in a
p53-dependent manner as a part of a negative feedback
mechanism [140,141]. Wip1
-/- MEFs exhibited a slight
increase in p53 phosphorylation at S15 and an increase
in the levels of p53 target p21 [140]. In an in vitro
assay, Wip1 could dephosphorylate p53 on S15 but not
S46 [106]. After IR, Wip1
-/- MEFs had an increase in
protein levels and S15 phosphorylation whereas knock-
down of Wip1 with siRNA resulted in increased p53
protein levels and S15 phosphorylation. In this system,
Wip1 did not have an effect on ATM or ATR after IR
or UV, respectively, therefore the effect on p53 seems to
be direct [106].
Wip1
-/- mice displayed a defect in T cell maturation
due to sustained p53 activation [142]. Wip1
-/- MEFs had
a more robust G1 arrest following IR, which may be due
to increased activity of p53 [140]. Wip1 was required for
recovery from arrest in G2 in a p53-dependent manner
[143]. Overexpression of Wip1 decreased the S-phase
and G2/M checkpoints whereas siRNA knockdown of
Wip1 increased the intensity and length of the S-phase
and G2/M checkpoints after UV and IR [106]. Interest-
ingly, the Wip1 gene was found to be amplified in 11%
of human breast tumors, most of which had wild-type
p53 [144]. These data collectively suggest that the
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high levels of Wip1 contributes to tumorigenesis.
N o to n l yi sp 5 3r e g u l a t e db ym ultiple protein serine/
threonine phosphatases directly, but it is also regulated
indirectly through the regulation of Mdm2. Mdm2 has
been predicted to be a Wip1 substrate [145]. Indeed,
Wip1, but not PP2A, dephosphorylated Mdm2 at S395,
which is an ATM phosphorylation site [79,146]. Wip1
dephosphorylation of S395 increased the stability of
Mdm2 and increased the Mdm2-p53 interaction. Wip1
inhibited Mdm2 auto-ubiquitination thereby stabilizing
the protein [146].
The multiple modes of regulation of p53 and its acti-
vation via negative feedback loops signifies the impor-
tance of keeping p53 tightly regulated after DNA
damage. Protein serine/threonine phosphatases play a
role in regulating p53 through direct dephosphorylation
via PP1, Wip1, and PP2A as well as enhancement of
Mdm2 negative regulation of p53 through Wip1.
Conclusions
In summary, recent literature has demonstrated that
protein serine/threonine phosphatases have important
functions both in the activation of the DDR and in its
negative regulation. At least, negative regulation oper-
ates at two levels: keeping proteins in an inactive state
and inactivating them following the repair of the
damaged DNA. This regulation (Fig. 2) allows for the
system to remain in an inactive state but poised to
rapidly respond to damaged DNA as well as to recover
from cell cycle arrest and resume cell cycle progression.
The data discussed here seems to reveal a scenario
where multiple phosphatases target the same phosphor-
ylation events. While this could be construed as exces-
sive promiscuity of phosphatases we believe that a more
nuanced reading of the data should be performed. First,
the inherent limitations of different experimental
approaches should be kept in mind. For example,
genetic data (deletion or RNAi-mediated silencing) may
result in changes in phosphorylation of the target pro-
tein but the effects might be indirect; pharmacologic
inhibitors might have off target effects and suffer from
low specificity; in vitro assays might reveal that a certain
phosphatase can dephosphorylate a target but they may
never co-localize in the cell. Second, although multiple
phosphatases may target the same protein or phos-
phorylated residue they might have very specific func-
tions depending on the type of damage, tissue type, and
cell cycle compartment. Thus, although the general
themes of these regulatory steps have been recently
uncovered, working out the details and the dynamic
behavior of the system is going to keep investigators
busy for many years to come.
Additional material
Additional file 1: Table 1. Positive and negative regulators of specific
phosphorylation sites of proteins in the DNA Damage Response
Abbreviations
9-1-1 COMPLEX: Rad9-Rad1-Hus1; ATM: ataxia telangiectasia-mutated; ATR:
ataxia telangiectasia and Rad3-related; ATRIP: ATR-interacting protein; DDR:
DNA damage response; DNA-PK: DNA-dependent protein kinase; DSB:
double stranded break; IR: ionizing radiation; MEFS: mouse embryo
fibroblasts; MRN: Mre11-Rad50-Nbs1 complex; PCNA: proliferating cell nuclear
antigen; RFC: replication factor C; RPA: replication protein A; UV: ultraviolet
radiation.
Acknowledgements
Work in the Monteiro Lab is funded by the Florida Breast Cancer Coalition
Research Foundation pre-doctoral grant to A.F., by NIH award CA116167,
and by a National Functional Genomics Center award. We thank A. Velkova
for critical reading of the manuscript.
Author details
1Risk Assessment, Detection, and Intervention Program, H. Lee Moffitt Cancer
Center and Research Institute, Tampa, Florida, 33612, USA.
2University of
South Florida Cancer Biology PhD Program, Tampa, Florida 33612, USA.
3Present address: NCI-Frederick, P.O.Box B, Building 560, Mailstop 17,
Frederick, MD 21702 USA.
Authors’ contributions
AF and AM contributed to the preparation of the manuscript and approval
of its final version.
Competing interests
The authors declare that they have no competing interests.
Received: 13 July 2010 Accepted: 22 September 2010
Published: 22 September 2010
References
1. Zhou BB, Elledge SJ: The DNA damage response: putting checkpoints in
perspective. Nature 2000, 408:433-439.
2. Lukas J, Lukas C, Bartek J: Mammalian cell cycle checkpoints: signalling
pathways and their organization in space and time. DNA Repair (Amst)
2004, 3:997-1007.
3. Norbury CJ, Zhivotovsky B: DNA damage-induced apoptosis. Oncogene
2004, 23:2797-2808.
4. Gibson TJ: Cell regulation: determined to signal discrete cooperation.
Trends Biochem Sci 2009, 34:471-482.
5. Harper JW, Elledge SJ: The DNA damage response: ten years after. Mol
Cell 2007, 28:739-745.
6. Parrilla-Castellar ER, Arlander SJ, Karnitz L: Dial 9-1-1 for DNA damage: the
Rad9-Hus1-Rad1 (9-1-1) clamp complex. DNA Repair (Amst) 2004,
3:1009-1014.
7. Lee JH, Paull TT: Activation and regulation of ATM kinase activity in
response to DNA double-strand breaks. Oncogene 2007, 26:7741-7748.
8. Williams RS, Williams JS, Tainer JA: Mre11-Rad50-Nbs1 is a keystone
complex connecting DNA repair machinery, double-strand break
signaling, and the chromatin template. Biochem Cell Biol 2007, 85:509-520.
9. Zhou J, Lim CU, Li JJ, Cai L, Zhang Y: The role of NBS1 in the modulation
of PIKK family proteins ATM and ATR in the cellular response to DNA
damage. Cancer Lett 2006, 243:9-15.
10. Bermudez VP, Lindsey-Boltz LA, Cesare AJ, Maniwa Y, Griffith JD, Hurwitz J,
et al: Loading of the human 9-1-1 checkpoint complex onto DNA by the
checkpoint clamp loader hRad17-replication factor C complex in vitro.
Proc Natl Acad Sci USA 2003, 100:1633-1638.
11. Bakkenist CJ, Kastan MB: DNA damage activates ATM through
intermolecular autophosphorylation and dimer dissociation. Nature 2003,
421:499-506.
Freeman and Monteiro Cell Communication and Signaling 2010, 8:27
http://www.biosignaling.com/content/8/1/27
Page 9 of 1212. Daniel JA, Pellegrini M, Lee JH, Paull TT, Feigenbaum L, Nussenzweig A:
Multiple autophosphorylation sites are dispensable for murine ATM
activation in vivo. J Cell Biol 2008, 183:777-783.
13. Pellegrini M, Celeste A, Difilippantonio S, Guo R, Wang W, Feigenbaum L,
et al: Autophosphorylation at serine 1987 is dispensable for murine Atm
activation in vivo. Nature 2006, 443:222-225.
14. So S, Davis AJ, Chen DJ: Autophosphorylation at serine 1981 stabilizes
ATM at DNA damage sites. J Cell Biol 2009, 187:977-990.
15. Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y:
Requirement of the MRN complex for ATM activation by DNA damage.
EMBO J 2003, 22:5612-5621.
16. Lavin MF: The Mre11 complex and ATM: a two-way functional
interaction in recognising and signaling DNA double strand breaks. DNA
Repair (Amst) 2004, 3:1515-1520.
17. Cimprich KA, Cortez D: ATR: an essential regulator of genome integrity.
Nat Rev Mol Cell Biol 2008, 9:616-627.
18. Binz SK, Sheehan AM, Wold MS: Replication protein A phosphorylation
and the cellular response to DNA damage. DNA Repair (Amst) 2004,
3:1015-1024.
19. Smith GC, Jackson SP: The DNA-dependent protein kinase. Genes Dev
1999, 13:916-934.
20. Meek K, Dang V, Lees-Miller SP: DNA-PK: the means to justify the ends?
Adv Immunol 2008, 99:33-58.
21. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, Hurov KE, Luo J, et al:
ATM and ATR substrate analysis reveals extensive protein networks
responsive to DNA damage. Science 2007, 316:1160-1166.
22. Smolka MB, Albuquerque CP, Chen SH, Zhou H: Proteome-wide
identification of in vivo targets of DNA damage checkpoint kinases. Proc
Natl Acad Sci USA 2007, 104:10364-10369.
23. Bartek J, Lukas J: Chk1 and Chk2 kinases in checkpoint control and
cancer. Cancer Cell 2003, 3:421-429.
24. Bekker-Jensen S, Lukas C, Kitagawa R, Melander F, Kastan MB, Bartek J, et al:
Spatial organization of the mammalian genome surveillance machinery
in response to DNA strand breaks. The Journal of Cell Biology 2006,
173:195-206.
25. Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K, Elledge SJ: Ataxia
telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc
Natl Acad Sci USA 2000, 97:10389-10394.
26. Ahn JY, Schwarz JK, Piwnica-Worms H, Canman CE: Threonine 68
phosphorylation by ataxia telangiectasia mutated is required for
efficient activation of Chk2 in response to ionizing radiation. Cancer Res
2000, 60:5934-5936.
27. Melchionna R, Chen XB, Blasina A, McGowan CH: Threonine 68 is required
for radiation-induced phosphorylation and activation of Cds1. Nat Cell
Biol 2000, 2:762-765.
28. Xu X, Tsvetkov LM, Stern DF: Chk2 activation and phosphorylation-
dependent oligomerization. Mol Cell Biol 2002, 22:4419-4432.
29. Lee CH, Chung JH: The hCds1 (Chk2)-FHA domain is essential for a chain
of phosphorylation events on hCds1 that is induced by ionizing
radiation. J Biol Chem 2001, 276:30537-30541.
30. Takai H, Tominaga K, Motoyama N, Minamishima YA, Nagahama H,
Tsukiyama T, et al: Aberrant cell cycle checkpoint function and early
embryonic death in Chk1(-/-) mice. Genes Dev 2000, 14:1439-1447.
31. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, et al: Chk1 is an
essential kinase that is regulated by Atr and required for the G(2)/M
DNA damage checkpoint. Genes Dev 2000, 14:1448-1459.
32. Hirao A, Cheung A, Duncan G, Girard PM, Elia AJ, Wakeham A, et al: Chk2 is
a tumor suppressor that regulates apoptosis in both an ataxia
telangiectasia mutated (ATM)-dependent and an ATM-independent
manner. Mol Cell Biol 2002, 22:6521-6532.
33. Takai H, Naka K, Okada Y, Watanabe M, Harada N, Saito S, et al: Chk2-
deficient mice exhibit radioresistance and defective p53-mediated
transcription. EMBO J 2002, 21:5195-5205.
34. Kramer A, Mailand N, Lukas C, Syljuasen RG, Wilkinson CJ, Nigg EA, et al:
Centrosome-associated Chk1 prevents premature activation of cyclin-B-
Cdk1 kinase. Nat Cell Biol 2004, 6:884-891.
35. Stracker TH, Usui T, Petrini JH: Taking the time to make important
decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA
damage response. DNA Repair (Amst) 2009, 8:1047-1054.
36. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM: DNA double-
stranded breaks induce histone H2AX phosphorylation on serine 139. J
Biol Chem 1998, 273:5858-5868.
37. Rogakou EP, Boon C, Redon C, Bonner WM: Megabase chromatin domains
involved in DNA double-strand breaks in vivo. J Cell Biol 1999,
146:905-916.
38. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM:
A critical role for histone H2AX in recruitment of repair factors to
nuclear foci after DNA damage. Curr Biol 2000, 10:886-895.
39. Stewart GS, Wang B, Bignell CR, Taylor AM, Elledge SJ: MDC1 is a mediator
of the mammalian DNA damage checkpoint. Nature 2003, 421:961-966.
40. Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT,
Sedelnikova OA, et al: Genomic instability in mice lacking histone H2AX.
Science 2002, 296:922-927.
41. Bassing CH, Chua KF, Sekiguchi J, Suh H, Whitlow SR, Fleming JC, et al:
Increased ionizing radiation sensitivity and genomic instability in the
absence of histone H2AX. Proc Natl Acad Sci USA 2002, 99:8173-8178.
42. Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP:
MDC1 Directly Binds Phosphorylated Histone H2AX to Regulate Cellular
Responses to DNA Double-Strand Breaks. Cell 2005, 123:1213-1226.
43. Lukas C, Melander F, Stucki M, Falck J, Bekker-Jensen S, Goldberg M, et al:
Mdc1 couples DNA double-strand break recognition by Nbs1 with its
H2AX-dependent chromatin retention. EMBO J 2004, 23:2674-2683.
44. Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A,
et al: Histone H2AX phosphorylation is dispensable for the initial
recognition of DNA breaks. Nat Cell Biol 2003, 5:675-679.
45. Ouchi T: BRCA1 Phosphorylation: Biological Consequences. Cancer Biol
Ther 2006, 5:470-475.
46. Xu B, O’Donnell AH, Kim ST, Kastan MB: Phosphorylation of serine 1387 in
Brca1 is specifically required for the Atm-mediated S-phase checkpoint
after ionizing irradiation. Cancer Res 2002, 62:4588-4591.
47. Xu B, Kim S, Kastan MB: Involvement of Brca1 in S-phase and G(2)-phase
checkpoints after ionizing irradiation. Mol Cell Biol 2001, 21:3445-3450.
48. Cortez D, Wang Y, Qin J, Elledge SJ: Requirement of ATM-dependent
phosphorylation of brca1 in the DNA damage response to double-
strand breaks [see comments]. Science 1999, 286:1162-1166.
49. Kim ST, Lim DS, Canman CE, Kastan MB: Substrate Specificities and
Identification of Putative Substrates of ATM Kinase Family Members. J
Biol Chem 1999, 274:37538-37543.
50. Chaturvedi P, Eng WK, Zhu Y, Mattern MR, Mishra R, Hurle MR, et al:
Mammalian Chk2 is a downstream effector of the ATM-dependent DNA
damage checkpoint pathway. Oncogene 1999, 18:4047-4054.
51. Lee JS, Collins KM, Brown AL, Lee CH, Chung JH: hCds1-mediated
phosphorylation of BRCA1 regulates the DNA damage response. Nature
2000, 404:201-204.
52. Zhang J, Willers H, Feng Z, Ghosh JC, Kim S, Weaver DT, et al: Chk2
phosphorylation of BRCA1 regulates DNA double-strand break repair.
Mol Cell Biol 2004, 24:708-718.
53. Gatei M, Zhou BB, Hobson K, Scott S, Young D, Khanna KK: Ataxia
telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase
mediate phosphorylation of Brca1 at distinct and overlapping sites. In
vivo assessment using phospho-specific antibodies. J Biol Chem 2001,
276:17276-17280.
54. Snouwaert JN, Gowen LC, Latour AM, Mohn AR, Xiao A, DiBiase L, et al:
BRCA1 deficient embryonic stem cells display a decreased homologous
recombination frequency and an increased frequency of non-
homologous recombination that is corrected by expression of a brca1
transgene. Oncogene 1999, 18:7900-7907.
55. Wang HC, Chou WC, Shieh SY, Shen CY: Ataxia telangiectasia mutated
and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA
end-joining. Cancer Res 2006, 66:1391-1400.
56. Lee MS, Edwards RA, Thede GL, Glover JN: Structure of the BRCT repeat
domain of MDC1 and its specificity for the free COOH-terminal end of
the gamma-H2AX histone tail. J Biol Chem 2005, 280:32053-32056.
57. Lou Z, Minter-Dykhouse K, Wu X, Chen J: MDC1 is coupled to activated
CHK2 in mammalian DNA damage response pathways. Nature 2003,
421:957-961.
58. Mohammad DH, Yaffe MB: 14-3-3 proteins, FHA domains and BRCT
domains in the DNA damage response. DNA Repair (Amst) 2009,
8:1009-1017.
Freeman and Monteiro Cell Communication and Signaling 2010, 8:27
http://www.biosignaling.com/content/8/1/27
Page 10 of 1259. Kumagai A, Dunphy WG: Claspin, a novel protein required for the
activation of Chk1 during a DNA replication checkpoint response in
Xenopus egg extracts. Mol Cell 2000, 6:839-849.
60. Kumagai A, Kim SM, Dunphy WG: Claspin and the activated form of ATR-
ATRIP collaborate in the activation of Chk1. J Biol Chem 2004,
279:49599-49608.
61. Chini CC, Chen J: Human claspin is required for replication checkpoint
control. J Biol Chem 2003, 278:30057-30062.
62. Lin SY, Li K, Stewart GS, Elledge SJ: Human Claspin works with BRCA1 to
both positively and negatively regulate cell proliferation. Proc Natl Acad
Sci USA 2004, 101:6484-6489.
63. Chini CC, Chen J: Repeated phosphopeptide motifs in human Claspin are
phosphorylated by Chk1 and mediate Claspin function. J Biol Chem 2006,
281:33276-33282.
64. Donzelli M, Draetta GF: Regulating mammalian checkpoints through
Cdc25 inactivation. EMBO Rep 2003, 4:671-677.
65. Jin J, Shirogane T, Xu L, Nalepa G, Qin J, Elledge SJ, et al: SCFbeta-TRCP
links Chk1 signaling to degradation of the Cdc25A protein phosphatase.
Genes Dev 2003, 17:3062-3074.
66. Sorensen CS, Syljuasen RG, Falck J, Schroeder T, Ronnstrand L, Khanna KK,
et al: Chk1 regulates the S phase checkpoint by coupling the
physiological turnover and ionizing radiation-induced accelerated
proteolysis of Cdc25A. Cancer Cell 2003, 3:247-258.
67. Zeng Y, Piwnica-Worms H: DNA damage and replication checkpoints in
fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-
3-3 binding. Mol Cell Biol 1999, 19:7410-7419.
68. Bulavin DV, Higashimoto Y, Popoff IJ, Gaarde WA, Basrur V, Potapova O,
et al: Initiation of a G2/M checkpoint after ultraviolet radiation requires
p38 kinase. Nature 2001, 411:102-107.
69. Harris SL, Levine AJ: The p53 pathway: positive and negative feedback
loops. Oncogene 2005, 24:2899-2908.
70. Haupt Y, Maya R, Kazaz A, Oren M: Mdm2 promotes the rapid
degradation of p53. Nature 1997, 387:296-299.
71. Honda R, Tanaka H, Yasuda H: Oncoprotein MDM2 is a ubiquitin ligase E3
for tumor suppressor p53. FEBS Lett 1997, 420:25-27.
72. Kubbutat MH, Jones SN, Vousden KH: Regulation of p53 stability by
Mdm2. Nature 1997, 387:299-303.
73. Linares LK, Hengstermann A, Ciechanover A, Muller S, Scheffner M: HdmX
stimulates Hdm2-mediated ubiquitination and degradation of p53. Proc
Natl Acad Sci USA 2003, 100:12009-12014.
74. Poyurovsky MV, Priest C, Kentsis A, Borden KL, Pan ZQ, Pavletich N, et al:
The Mdm2 RING domain C-terminus is required for supramolecular
assembly and ubiquitin ligase activity. EMBO J 2007, 26:90-101.
75. Uldrijan S, Pannekoek WJ, Vousden KH: An essential function of the
extreme C-terminus of MDM2 can be provided by MDMX. EMBO J 2007,
26:102-112.
76. Shieh SY, Ikeda M, Taya Y, Prives C: DNA damage-induced
phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997,
91:325-334.
77. Shieh SY, Ahn J, Tamai K, Taya Y, Prives C: The human homologs of
checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple
DNA damage-inducible sites. Genes Dev 2000, 14:289-300.
78. Appella E, Anderson CW: Post-translational modifications and activation
of p53 by genotoxic stresses. Eur J Biochem 2001, 268:2764-2772.
79. Maya R, Balass M, Kim ST, Shkedy D, Leal JF, Shifman O, et al: ATM-
dependent phosphorylation of Mdm2 on serine 395: role in p53
activation by DNA damage. Genes Dev 2001, 15:1067-1077.
80. Shinozaki T, Nota A, Taya Y, Okamoto K: Functional role of Mdm2
phosphorylation by ATR in attenuation of p53 nuclear export. Oncogene
2003, 22:8870-8880.
81. Pereg Y, Shkedy D, de GP, Meulmeester E, Edelson-Averbukh M, Salek M,
et al: Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent
degradation in response to DNA damage. Proc Natl Acad Sci USA 2005,
102:5056-5061.
82. LeBron C, Chen L, Gilkes DM, Chen J: Regulation of MDMX nuclear import
and degradation by Chk2 and 14-3-3. EMBO J 2006, 25:1196-1206.
83. Chen L, Gilkes DM, Pan Y, Lane WS, Chen J: ATM and Chk2-dependent
phosphorylation of MDMX contribute to p53 activation after DNA
damage. EMBO J 2005, 24:3411-3422.
84. Lin WC, Lin FT, Nevins JR: Selective induction of E2F1 in response to DNA
damage, mediated by ATM-dependent phosphorylation. Genes Dev 2001,
15:1833-1844.
85. Stevens C, Smith L, La Thangue NB: Chk2 activates E2F-1 in response to
DNA damage. Nat Cell Biol 2003, 5:401-409.
86. Batchelor E, Mock CS, Bhan I, Loewer A, Lahav G: Recurrent initiation: a
mechanism for triggering p53 pulses in response to DNA damage. Mol
Cell 2008, 30:277-289.
87. Harris DR, Bunz F: Protein phosphatases and the dynamics of the DNA
damage response. Cell Cycle 2010, 9(5):861-869.
88. Virshup DM, Shenolikar S: From promiscuity to precision: protein
phosphatases get a makeover. Mol Cell 2009, 33:537-545.
89. Lu X, Nguyen TA, Moon SH, Darlington Y, Sommer M, Donehower LA: The
type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor
and DNA damage response pathways. Cancer Metastasis Rev 2008,
27:123-135.
90. Keogh MC, Kim JA, Downey M, Fillingham J, Chowdhury D, Harrison JC,
et al: A phosphatase complex that dephosphorylates gammaH2AX
regulates DNA damage checkpoint recovery. Nature 2006,
26:439(7075):497-501.
91. Chowdhury D, Keogh MC, Ishii H, Peterson CL, Buratowski S, Lieberman J:
gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates
DNA double-strand break repair. Mol Cell 2005, 20:801-809.
92. Nazarov IB, Smirnova AN, Krutilina RI, Svetlova MP, Solovjeva LV,
Nikiforov AA, et al: Dephosphorylation of histone gamma-H2AX during
repair of DNA double-strand breaks in mammalian cells and its
inhibition by calyculin A. Radiat Res 2003, 160:309-317.
93. Chowdhury D, Xu X, Zhong X, Ahmed F, Zhong J, Liao J, et al: A PP4-
phosphatase complex dephosphorylates gamma-H2AX generated
during DNA replication. Mol Cell 2008, 31:33-46.
94. Nakada S, Chen GI, Gingras AC, Durocher D: PP4 is a gamma H2AX
phosphatase required for recovery from the DNA damage checkpoint.
EMBO Rep 2008, 9:1019-1026.
95. Douglas P, Zhong J, Ye R, Moorhead GB, Xu X, Lees-Miller SP: Protein
phosphatase 6 interacts with the DNA-dependent protein kinase
catalytic subunit and dephosphorylates gamma-H2AX. Mol Cell Biol 2010,
30:1368-1381.
96. Macurek L, Lindqvist A, Voets O, Kool J, Vos HR, Medema RH: Wip1
phosphatase is associated with chromatin and dephosphorylates
gammaH2AX to promote checkpoint inhibition. Oncogene 2010,
15;29(15):2281-91.
97. Moon SH, Lin L, Zhang X, Nguyen TA, Darlington Y, Waldman AS, et al:
Wildtype p53-induced phosphatase 1 dephosphorylates histone variant
{gamma}-H2AX and suppresses DNA double strand break repair. J Biol
Chem 2010, 23:285(17):12935-47.
98. Krishnan N, Jeong DG, Jung SK, Ryu SE, Xiao A, Allis CD, et al:
Dephosphorylation of the C-terminal Tyrosyl Residue of the DNA
Damage-related Histone H2A.X Is Mediated by the Protein Phosphatase
Eyes Absent. J Biol Chem 2009, 284:16066-16070.
99. Jackson SP, Bartek J: The DNA-damage response in human biology and
disease. Nature 2009, 461:1071-1078.
100. San Filippo J, Sung P, Klein H: Mechanism of eukaryotic homologous
recombination. Annu Rev Biochem 2008, 77:229-257.
101. Feng J, Wakeman T, Yong S, Wu X, Kornbluth S, Wang XF: Protein
phosphatase 2A-dependent dephosphorylation of replication protein A
is required for the repair of DNA breaks induced by replication stress.
Mol Cell Biol 2009, 29:5696-5709.
102. Guo CY, Brautigan DL, Larner JM: ATM-dependent dissociation of B55
regulatory subunit from nuclear PP2A in response to ionizing radiation.
J Biol Chem 2002, 277:4839-4844.
103. Goodarzi AA, Jonnalagadda JC, Douglas P, Young D, Ye R, Moorhead GB,
et al: Autophosphorylation of ataxia-telangiectasia mutated is regulated
by protein phosphatase 2A. EMBO J 2004, 23:4451-4461.
104. Shreeram S, Demidov ON, Hee WK, Yamaguchi H, Onishi N, Kek C, et al:
Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol
Cell 2006, 23:757-764.
105. Shreeram S, Hee WK, Demidov ON, Kek C, Yamaguchi H, Fornace AJ, et al:
Regulation of ATM/p53-dependent suppression of myc-induced
lymphomas by Wip1 phosphatase. J Exp Med 2006, 203:2793-2799.
106. Lu X, Nannenga B, Donehower LA: PPM1 D dephosphorylates Chk1 and
p53 and abrogates cell cycle checkpoints. Genes Dev 2005, 19:1162-1174.
Freeman and Monteiro Cell Communication and Signaling 2010, 8:27
http://www.biosignaling.com/content/8/1/27
Page 11 of 12107. Ali A, Zhang J, Bao S, Liu I, Otterness D, Dean NM, et al: Requirement of
protein phosphatase 5 in DNA-damage-induced ATM activation. Genes
Dev 2004, 18:249-254.
108. Yong W, Bao S, Chen H, Li D, Sanchez ER, Shou W: Mice lacking protein
phosphatase 5 are defective in ataxia telangiectasia mutated (ATM)-
mediated cell cycle arrest. J Biol Chem 2007, 282:14690-14694.
109. Zhang J, Bao S, Furumai R, Kucera KS, Ali A, Dean NM, et al: Protein
phosphatase 5 is required for ATR-mediated checkpoint activation. Mol
Cell Biol 2005, 25:9910-9919.
110. Merkle D, Douglas P, Moorhead GB, Leonenko Z, Yu Y, Cramb D, et al: The
DNA-dependent protein kinase interacts with DNA to form a protein-
DNA complex that is disrupted by phosphorylation. Biochemistry 2002,
41:12706-12714.
111. Douglas P, Moorhead GB, Ye R, Lees-Miller SP: Protein phosphatases
regulate DNA-dependent protein kinase activity. J Biol Chem 2001,
276:18992-18998.
112. Chan DW, Lees-Miller SP: The DNA-dependent protein kinase is
inactivated by autophosphorylation of the catalytic subunit. J Biol Chem
1996, 271:8936-8941.
113. Wang Q, Gao F, Wang T, Flagg T, Deng X: A nonhomologous end-joining
pathway is required for protein phosphatase 2A promotion of DNA
double-strand break repair. Neoplasia 2009, 11:1012-1021.
114. Mi J, Dziegielewski J, Bolesta E, Brautigan DL, Larner JM: Activation of DNA-
PK by ionizing radiation is mediated by protein phosphatase 6. PLoS
ONE 2009, 4:e4395.
115. den Elzen NR, O’Connell MJ: Recovery from DNA damage checkpoint
arrest by PP1-mediated inhibition of Chk1. EMBO J 2004, 23:908-918.
116. McGowan CH, Russell P: The DNA damage response: sensing and
signaling. Curr Opin Cell Biol 2004, 16:629-633.
117. Bartek J, Falck J, Lukas J: CHK2 kinase–a busy messenger. Nat Rev Mol Cell
Biol 2001, 2:877-886.
118. Leung-Pineda V, Ryan CE, Piwnica-Worms H: Phosphorylation of Chk1 by
ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit.
Mol Cell Biol 2006, 26:7529-7538.
119. Petersen P, Chou DM, You Z, Hunter T, Walter JC, Walter G: Protein
phosphatase 2A antagonizes ATM and ATR in a Cdk2- and Cdc7-
independent DNA damage checkpoint. Mol Cell Biol 2006, 26:1997-2011.
120. Leroy C, Lee SE, Vaze MB, Ochsenbien F, Guerois R, Haber JE, et al: PP2C
phosphatases Ptc2 and Ptc3 are required for DNA checkpoint
inactivation after a double-strand break. Mol Cell 2003, 11:827-835.
121. Guillemain G, Ma E, Mauger S, Miron S, Thai R, Guerois R, et al: Mechanisms
of checkpoint kinase Rad53 inactivation after a double-strand break in
Saccharomyces cerevisiae. Mol Cell Biol 2007, 27:3378-3389.
122. O’Neill BM, Szyjka SJ, Lis ET, Bailey AO, Yates JR, Aparicio OM, et al: Pph3-
Psy2 is a phosphatase complex required for Rad53 dephosphorylation
and replication fork restart during recovery from DNA damage. Proc Natl
Acad Sci USA 2007, 104:9290-9295.
123. Travesa A, Duch A, Quintana DG: Distinct phosphatases mediate the
deactivation of the DNA damage checkpoint kinase Rad53. J Biol Chem
2008, 283:17123-17130.
124. Dozier C, Bonyadi M, Baricault L, Tonasso L, Darbon JM: Regulation of Chk2
phosphorylation by interaction with protein phosphatase 2A via its B’
regulatory subunit. Biol Cell 2004, 96:509-517.
125. Liang X, Reed E, Yu JJ: Protein phosphatase 2A interacts with Chk2 and
regulates phosphorylation at Thr-68 after cisplatin treatment of human
ovarian cancer cells. Int J Mol Med 2006, 17:703-708.
126. Freeman AK, Dapic V, Monteiro AN: Negative regulation of CHK2 activity
by protein phosphatase 2A is modulated by DNA damage. Cell Cycle
2010, 9:736-747.
127. Smolka M: Fine-tuning the DNA damage response: Protein Phosphatase
2A checks on CHK2. Cell Cycle 2010, 9(1):862-3, 9(5).
128. Yoda A, Xu XZ, Onishi N, Toyoshima K, Fujimoto H, Kato N, et al: Intrinsic
Kinase Activity and SQ/TQ Domain of Chk2 Kinase as Well as N-terminal
Domain of Wip1 Phosphatase Are Required for Regulation of Chk2 by
Wip1. J Biol Chem 2006, 281:24847-24862.
129. Fujimoto H, Onishi N, Kato N, Takekawa M, Xu XZ, Kosugi A, et al:
Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1
phosphatase. Cell Death Differ 2006, 13:1170-1180.
130. Oliva-Trastoy M, Berthonaud V, Chevalier A, Ducrot C, Marsolier-Kergoat MC,
Mann C, et al: The Wip1 phosphatase (PPM1D) antagonizes activation of
the Chk2 tumour suppressor kinase. Oncogene 2007, 26:1449-1458.
131. Yoda A, Toyoshima K, Watanabe Y, Onishi N, Hazaka Y, Tsukuda Y, et al:
Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting
oncogenic Wip1 phosphatase. J Biol Chem 2008, 283:18969-18979.
132. Fuku T, Semba S, Yutori H, Yokozaki H: Increased wild-type p53-induced
phosphatase 1 (Wip1 or PPM1D) expression correlated with
downregulation of checkpoint kinase 2 in human gastric carcinoma.
Pathol Int 2007, 57:566-571.
133. Yu YM, Pace SM, Allen SR, Deng CX, Hsu LC: A PP1-binding motif present
in BRCA1 plays a role in its DNA repair function. Int J Biol Sci 2008,
4:352-361.
134. Liu Y, Virshup DM, White RL, Hsu LC: Regulation of BRCA1
phosphorylation by interaction with protein phosphatase 1alpha. Cancer
Res 2002, 62:6357-6361.
135. Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL: The interaction
of PP1 with BRCA1 and analysis of their expression in breast tumors.
BMC Cancer 2007, 7:85.
136. Messner DJ, Romeo C, Boynton A, Rossie S: Inhibition of PP2A, but not
PP5, mediates p53 activation by low levels of okadaic acid in rat liver
epithelial cells. J Cell Biochem 2006, 99:241-255.
137. Dohoney KM, Guillerm C, Whiteford C, Elbi C, Lambert PF, Hager GL, et al:
Phosphorylation of p53 at serine 37 is important for transcriptional
activity and regulation in response to DNA damage. Oncogene 2004,
23:49-57.
138. Li DW, Fass U, Huizar I, Spector A: Okadaic acid-induced lens epithelial
cell apoptosis requires inhibition of phosphatase-1 and is associated
with induction of gene expression including p53 and bax. Eur J Biochem
1998, 257:351-361.
139. Li DW, Liu JP, Schmid PC, Schlosser R, Feng H, Liu WB, et al: Protein serine/
threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to
modulate its transcriptional and apoptotic activities. Oncogene 2006,
25:3006-3022.
140. Choi J, Nannenga B, Demidov ON, Bulavin DV, Cooney A, Brayton C, et al:
Mice deficient for the wild-type p53-induced phosphatase gene (Wip1)
exhibit defects in reproductive organs, immune function, and cell cycle
control. Mol Cell Biol 2002, 22:1094-1105.
141. Fiscella M, Zhang H, Fan S, Sakaguchi K, Shen S, Mercer WE, et al: Wip1, a
novel human protein phosphatase that is induced in response to
ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci USA
1997, 94:6048-6053.
142. Schito ML, Demidov ON, Saito S, Ashwell JD, Appella E: Wip1 phosphatase-
deficient mice exhibit defective T cell maturation due to sustained p53
activation. J Immunol 2006, 176:4818-4825.
143. Lindqvist A, de BM, Macurek L, Bras A, Mensinga A, Bruinsma W, et al: Wip1
confers G2 checkpoint recovery competence by counteracting p53-
dependent transcriptional repression. EMBO J 2009, 28:3196-3206.
144. Bulavin DV, Demidov ON, Saito S, Kauraniemi P, Phillips C, Amundson SA,
et al: Amplification of PPM1 D in human tumors abrogates p53 tumor-
suppressor activity. Nat Genet 2002, 31:210-215.
145. Yamaguchi H, Durell SR, Chatterjee DK, Anderson CW, Appella E: The Wip1
phosphatase PPM1 D dephosphorylates SQ/TQ motifs in checkpoint
substrates phosphorylated by PI3K-like kinases. Biochemistry 2007,
46:12594-12603.
146. Lu X, Ma O, Nguyen TA, Jones SN, Oren M, Donehower LA: The Wip1
Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory
loop. Cancer Cell 2007, 12:342-354.
doi:10.1186/1478-811X-8-27
Cite this article as: Freeman and Monteiro: Phosphatases in the cellular
response to DNA damage. Cell Communication and Signaling 2010 8:27.
Freeman and Monteiro Cell Communication and Signaling 2010, 8:27
http://www.biosignaling.com/content/8/1/27
Page 12 of 12